Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study - Bénard-Laribière, A; Miremont-Salamé, G; Pérault-Pochat, M-C; Noize, P; Haramburu, F (Fundam Clin Pharmacol, 2015)
; the EMIR Study Group on behalf of the French network of pharmacovigilance centres.